Yasuyuki Sato
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2023
Validity of computed mean compressed fibroglandular tissue thickness and breast composition for stratification of masking risk in Japanese women.
Journal: Breast cancer (Tokyo, Japan)
Published: September 25, 2022
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: May 01, 2020
Polygon method: A systematic margin assessment for breast conservation.
Journal: Cancer medicine
Published: January 03, 2019
Can quantitative evaluation of mammographic breast density, "volumetric measurement", predict the masking risk with dense breast tissue? Investigation by comparison with subjective visual estimation by Japanese radiologists.
Journal: Breast cancer (Tokyo, Japan)
Published: June 17, 2018
Diagnostic performance of digital breast tomosynthesis and full-field digital mammography with new reconstruction and new processing for dose reduction.
Journal: Breast cancer (Tokyo, Japan)
Published: July 27, 2017
Detectability comparison of modes in dual-mode digital breast tomosynthesis.
Journal: Breast cancer (Tokyo, Japan)
Published: May 16, 2016
Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity.
Journal: Virchows Archiv : an international journal of pathology
Published: August 30, 2014
Pseudo-micropapillary structures associated with columnar cell lesions of the breast are an artifact due to traumatic epithelial detachment: a potential pitfall which can lead to overtreatment.
Journal: Virchows Archiv : an international journal of pathology
Published: May 12, 2013
A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer.
Journal: Breast cancer research and treatment
Published: March 15, 2013
Last Updated: 09/26/2026